MDSCs can also indirectly suppress anti-tumor immunity, through inhibition of TILs and the generation of regulatory T-cells (Tregs) in the tumor microenvironment following their production of TGF-β and several cytokines (82). The gene discussed is TGFB1; the disease is neoplasm.